California Public Employees Retirement System’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

California Public Employees Retirement System’s Portfolio IMUC Stock Details IMUC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,228	Closed	-$25K	–	3531
2016 Q3	$25K	Hold	5,228	–	–	﹤0.01%	3434
2016 Q2	$48K	Hold	5,228	–	–	﹤0.01%	3441
2016 Q1	$61K	Hold	5,228	–	–	﹤0.01%	3417
2015 Q4	$74K	Hold	5,228	–	–	﹤0.01%	3429
2015 Q3	$88K	Hold	5,228	–	–	﹤0.01%	3420
2015 Q2	$99K	Hold	5,228	–	–	﹤0.01%	3472
2015 Q1	$146K	Hold	5,228	–	–	﹤0.01%	3519
2014 Q4	$146K	Hold	5,228	–	–	﹤0.01%	3519
2014 Q3	$186K	Hold	5,228	–	–	﹤0.01%	3426
2014 Q2	$234K	Buy	+5,228	New	+$252K	﹤0.01%	3367
2013 Q3	–	Sell	-45	Closed	-$3K	–	4077
2013 Q2	$3K	Buy	+45	New	+$4.31K	﹤0.01%	3962

Other funds holding IMUC

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

California Public Employees Retirement System's IMUC Position: Q4 2016 in Review

California Public Employees Retirement System sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2016, closing a stake of 5,228 shares — an estimated $25K sold.

California Public Employees Retirement System first reported a position in IMUC in Q2 2013 and held it in 11 quarters. The position peaked at $234K in Q2 2014. 16 funds tracked by Wall St. Rank hold IMUC as of Q4 2016.

California Public Employees Retirement System reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2016 after selling out during the quarter.
California Public Employees Retirement System sold 5,228 ImmunoCellular Therapeutics, Ltd. shares in Q4 2016, an estimated $25K.
California Public Employees Retirement System first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2013 and held it in 11 quarters.
California Public Employees Retirement System's ImmunoCellular Therapeutics, Ltd. position peaked at $234K in Q2 2014.
16 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2016.

Based on California Public Employees Retirement System's 13F filing for Q4 2016, filed 10 Feb 2017.